Publications by authors named "Yuichi Tambo"

Claim this Profile
P
Perioperative Nivolumab in Resectable Non-Small Cell Lung Cancer: A Subanalysis of Japanese Patients From Checkmate 77T.
Fumihiro Tanaka, Yasutaka Watanabe, Shunichi Sugawara, Jiro Okami, Satoshi Muto, Yuichi Tambo

Cancer Sci· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MET Enhances Amivantamab Binding to EGFR and Antibody-Dependent Cellular Toxicity.
Shigeki Sato, Neval Yilmaz, Sachiko Arai, Katsuya Sakai, Hiroki Sato, Yuichi Tambo

Cancer Sci· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms of resistance to antibody-drug conjugates in cancers.
Yuya Murase, Shigeki Nanjo, Tsukasa Ueda, Yifeng Liu, Shunichi Nomura, Yuichi Tambo

Respir Investig· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 72-Year-Old Man With Progressive Dyspnea and Diffuse Lung Disease.
Ryo Hara, Satoshi Watanabe, Yuya Murase, Tsukasa Ueda, Atsushi Muto, Yuichi Tambo

Chest· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Five-year efficacy and safety of pembrolizumab as first-line treatment in patients with non-small cell lung cancer with PD-L1 tumor proportion score ≥50 %: A multicenter observational study.
Yuichi Tambo, Takashi Sone, Koichi Nishi, Kazuhiko Shibata, Toshiyuki Kita

Lung Cancer· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of immune checkpoint inhibitor plus chemotherapy or ipilimumab plus nivolumab-based therapy for NSCLC patients with PD-L1 TPS (1-49 %): TOPGAN2023-01.
Hisashi Tanaka, Tomonori Makiguchi, Takehiro Tozuka, Yosuke Kawashima, Tomohiro Oba, Yuichi Tambo

Eur J Cancer· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
combined with L858R mutation reduced afatinib sensitivity and associated to early recurrence in lung cancer.
Nanao Terada, Hayato Koba, Shigeki Nanjo, Hideharu Kimura, Akihiro Nishiyama, Yuichi Tambo

Transl Lung Cancer Res· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artemis: A Multicenter, Open-Label, Single-Arm, Phase II Study to Evaluate the Efficacy and Safety of First-Line Carboplatin/Paclitaxel/Lenvatinib/Pembrolizumab Combination for Previously Untreated Advanced or Recurrent Thymic Carcinomas.
Yusuke Okuma, Shogo Nomura, Jun Sakakibara-Konishi, Yoko Tsukita, Shuji Murakami, Yuichi Tambo

Clin Lung Cancer· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of coexisting conditions and complications in pleuroparenchymal fibroelastosis: a single-center retrospective study.
Kazuhiko Iwasaki, Satoshi Watanabe, Kazumasa Kase, Noriyuki Ohkura, Keigo Saeki, Yuichi Tambo

Sarcoidosis Vasc Diffuse Lung Dis· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic evolutional analysis of surgical resected specimen to assess osimertinib as a first-line therapy in two patients with lung cancer harboring EGFR mutation: Case series.
Hayato Koba, Taro Yoneda, Hiroko Morita, Hideharu Kimura, Yuya Murase, Yuichi Tambo

Thorac Cancer· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients with idiopathic pulmonary fibrosis and refractory cough have traction bronchiectasis and distorted airway architecture: a retrospective case review study.
Kenta Yamamura, Johsuke Hara, Satoshi Watanabe, Takafumi Kobayashi, Kazumasa Kase, Yuichi Tambo

J Thorac Dis· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NOTCH1 and CREBBP co-mutations negatively affect the benefit of adjuvant therapy in completely resected EGFR-mutated NSCLC: translational research of phase III IMPACT study.
Satoshi Ikeda, Masahiro Tsuboi, Kazuko Sakai, Toshihiro Misumi, Hiroaki Akamatsu, Yuichi Tambo

Mol Oncol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unexpected Diffuse Alveolar Hemorrhage After Bronchoscopy.
Saya Tsukida, Satoshi Watanabe, Masato Hongo, Yuya Murase, Yoshihiro Yamamoto, Yuichi Tambo

Chest· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subsequent treatment for locally advanced non-small-cell lung cancer that progressed after definitive chemoradiotherapy and consolidation therapy with durvalumab: a multicenter retrospective analysis (TOPGAN 2021-02).
Tsukasa Hasegawa, Ryo Ariyasu, Hisashi Tanaka, Ryota Saito, Yosuke Kawashima, Yuichi Tambo

Cancer Chemother Pharmacol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bronchial Thermoplasty Attenuates Cough Reflex Sensitivity in Severe Asthma : A Single-Center Retrospective Study with 2-year Follow-up.
Johsuke Hara, Kenta Yamamura, Tamami Sakai, Yoshihiro Takeda, Takafumi Kobayashi, Yuichi Tambo

J Med Invest· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical efficacy of amrubicin in patients with small cell lung cancer relapse after first-line treatment including immune checkpoint inhibitors: A retrospective multicenter study (TOPGAN 2021-01).
Shinya Uematsu, Satoru Kitazono, Hisashi Tanaka, Ryota Saito, Yosuke Kawashima, Yuichi Tambo

Thorac Cancer· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An open-label, crossover study to compare different formulations and evaluate effect of food on pharmacokinetics of pimitespib in patients with advanced solid tumors.
Yoshito Komatsu, Tsuneo Shimokawa, Kohei Akiyoshi, Masato Karayama, Akihiko Shimomura, Yuichi Tambo

Invest New Drugs· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Survival of Patients With Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitor Monotherapy in Real-World Settings.
Taro Yoneda, Takashi Sone, Hayato Koba, Kazuhiko Shibata, Junya Suzuki, Yuichi Tambo

Clin Lung Cancer· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical efficacy of dacomitinib in rechallenge setting for patients with epidermal growth factor receptor mutant non-small cell lung cancer: A multicenter retrospective analysis (TOPGAN2020-02).
Hisashi Tanaka, Hiroaki Sakamoto, Takahiro Akita, Fumiyoshi Ohyanagi, Yosuke Kawashima, Yuichi Tambo

Thorac Cancer· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interstitial pneumonitis after COVID-19 vaccination: A report of three cases.
Takahiro Shimizu, Satoshi Watanabe, Tomoaki Yoneda, Masaki Kinoshita, Nanao Terada, Yuichi Tambo

Allergol Int· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two cases of chronic obstructive pulmonary disease evaluated by dynamic-ventilatory digital radiography for pulmonary function and assessment of treatment efficacy.
Noriyuki Ohkura, Rie Tanaka, Johsuke Hara, Naohiko Ogawa, Miki Abo, Yuichi Tambo

Respir Investig· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
alteration in -mutated lung adenocarcinoma leads to histological small-cell carcinoma transformation under EGFR-TKI treatment.
Hayato Koba, Hideharu Kimura, Taro Yoneda, Naohiko Ogawa, Kota Tanimura, Yuichi Tambo

Transl Lung Cancer Res· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suitability of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration versus Paired Transbronchial Biopsy Specimens for Evaluating Programmed Death Ligand-1 Expression in Stage III and IV Lung Cancer: A Comparative Retrospective Study.
Hiroki Matsuoka, Tomoyuki Araya, Toshiyuki Kita, Nanao Terada, Kenta Yamamura, Yuichi Tambo

J Cancer· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of the combination of S-1 with bevacizumab for patients with previously treated advanced non-squamous non-small-cell lung cancer.
Tsukasa Hasegawa, Noriko Yanagitani, Fumiyoshi Ohyanagi, Keita Kudo, Atsushi Horiike, Yuichi Tambo

Int J Clin Oncol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of S-1 treatment as palliative-intent chemotherapy for previously treated advanced thymic carcinoma.
Yusuke Okuma, Yasushi Goto, Fumiyoshi Ohyanagi, Kuniko Sunami, Yoshiro Nakahara, Yuichi Tambo

Cancer Med· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis